Facial Wrinkles Clinical Trial
Official title:
A Prospective, Multicenter, Single Arm Clinical Study Evaluating the Use of J-Plasma® for Dermal Resurfacing
This study evaluates the safety and effectiveness of J-Plasma in the reduction of facial wrinkles and rhytides. It is a multi-center, single arm, evaluator-blind prospective study of 55 study subjects who are seeking a procedure to reduce the appearance of wrinkles and rhytides and will be conducted at up to 5 investigational centers in the United States. Each study subject will receive one procedure with J-Plasma at enrollment. Follow-up will occur immediately following the procedure, at 10 days, 1, 3, and 6 months after enrollment.
The study objective is to demonstrate the safety and efficacy of the J-Plasma system for use in dermal skin resurfacing. This is a multi-center, single arm, evaluator-blind prospective study of 55 study subjects who are seeking a procedure to reduce the appearance of wrinkles and rhytides at up to 5 investigational centers in the United States. Study subjects that meet study eligibility criteria and have provided informed consent will be enrolled in the study. During the procedure, the investigators will use J-Plasma on applicable facial zones to reduce wrinkles and rhytides. Study subjects will be followed immediately following the procedure, at 10 days, 1, 3, and 6 months post-procedure for study assessments. Study enrollment is expected to occur over 3-6 months. Imaging and study assessments will continue through 6 months post-procedure. Total study duration is expected to be approximately 9-12 months. Primary study endpoints will be assessed at 3 months following the procedure. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01447342 -
A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines
|
Phase 2/Phase 3 | |
| Completed |
NCT00978887 -
Retorna Facial Cream in the Treatment of Facial Wrinkles
|
Phase 3 | |
| Completed |
NCT00414544 -
Evaluation of the Safety and Efficacy of CosmetaLife™ for the Correction of Nasolabial Folds
|
Phase 2 | |
| Completed |
NCT00888914 -
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
|
Phase 2 | |
| Completed |
NCT00877279 -
Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft
|
Phase 3 | |
| Completed |
NCT01124565 -
Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
|
Phase 2 | |
| Completed |
NCT00922623 -
Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI
|
N/A | |
| Not yet recruiting |
NCT03836638 -
The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment
|
N/A | |
| Not yet recruiting |
NCT06322875 -
A Clinical Study to Evaluate the Efficacy and Satisfaction of RHC Serum Combined With RHC(III) Injection
|
N/A | |
| Completed |
NCT01566396 -
Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles
|
N/A | |
| Completed |
NCT01151436 -
Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers
|
N/A | |
| Completed |
NCT06321770 -
Oral Supplementation With Active Collagen Peptides and Skin Health Improvement
|
N/A | |
| Completed |
NCT01379365 -
Cryo-Touch III Refinement Study Investigational Plan
|
Phase 2/Phase 3 | |
| Completed |
NCT00288470 -
A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.
|
N/A | |
| Completed |
NCT02122536 -
Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles
|
N/A | |
| Completed |
NCT01167140 -
Cryo-Touch II for the Treatment of Wrinkles
|
Phase 2/Phase 3 | |
| Completed |
NCT00968825 -
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
|
Phase 2 | |
| Completed |
NCT01064518 -
Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
|
Phase 2 | |
| Completed |
NCT00417469 -
A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
|
Phase 3 | |
| Completed |
NCT00293163 -
A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
|
Phase 4 |